DS-1062, a TROP2-targeting ADC with a Novel DNA Topoisomerase Inhibitor
Time: 9:10 am
day: Day One
Details:
- DXd-ADC: Widely applicable technology platform
- Preclinical results on the mechanism of action of DS-1062
- Updates on clinical development of DS-1062